DCF — THREE RIVERS HEALTH
Enterprise Value: $-152.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-152.9M
Enterprise Value
$-47.4M
PV of Cash Flows
$-105.5M
PV of Terminal Value
$-169.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $65.8M | $-10.1M | -15.0% | $-12.9M | $-11.7M |
| Year 2 | $67.8M | $-9.7M | -14.0% | $-12.6M | $-10.4M |
| Year 3 | $69.9M | $-9.3M | -13.0% | $-12.2M | $-9.2M |
| Year 4 | $72.0M | $-9.2M | -13.0% | $-12.3M | $-8.4M |
| Year 5 | $74.1M | $-9.3M | -13.0% | $-12.4M | $-7.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-152.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$63.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15796399765844482
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5